With the care costs for the thousands of new cases predicted to occur by 2031, can we afford “business as usual”?
The group A streptococcus (GAS) bacterium causes possibly the most diverse range of diseases compared with any other pathogen. Resulting from an autoimmune reaction to GAS throat infection, and possibly skin infection, acute rheumatic fever (ARF) and its common consequence of rheumatic heart disease (RHD) have been described as “diseases of poverty” because they are highly prevalent in socio‐economic disadvantaged settings.1 Although there is a clear gradient between disease prevalence and socio‐economic disadvantage, ARF and RHD were once also prevalent in low and high socio‐economic settings, including in Melbourne, among non‐Indigenous Australians during the 1930s and 1940s.2 That ARF rarely, if at all, occurs in modern Melbourne is testament to the reality that ARF and RHD can be eliminated Australia‐wide, but what will elimination of ARF and RHD take and can we afford “business as usual”?
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers 2016; 2: 15084.
- 2. Holmes MC, Rubbo SD. A study of rheumatic fever and streptococcal infection in different social groups in Melbourne. J Hyg (Lond) 1953; 51: 450–457.
- 3. Colquhoun S, Condon J, Qin Li S, et al. Disparity in mortality rates from rheumatic heart disease in the Australian indigenous and non‐indigenous populations. Global Heart 2014; 9: e259–e260.
- 4. Australian Institute of Health and Welfare. Rheumatic heart disease and acute rheumatic fever in Australia: 1996–2012 (AIHW Cat. No. CVD 60). Canberra: AIHW, 2013. https://www.aihw.gov.au/reports/heart-stroke-vascular-disease/rheumatic-heart-disease-and-acute-rheumatic-fever/contents/table-of-contents (viewed July 2019).
- 5. Australian Institute of Health and Welfare. Australian Burden of Disease Study: impact and causes of illness and death in Aboriginal and Torres Strait Islander people 2011 (AIHW Cat. No. BOD 7). Canberra: AIHW, 2016. https://www.aihw.gov.au/reports/burden-of-disease/australian-bod-study-2011-indigenous-australians/contents/table-of-contents (viewed July 2019).
- 6. Roberts K, Maguire G, Brown A, et al. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation 2014; 129: 1953–1961.
- 7. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 2002; (3): CD002227.
- 8. Health Policy Analysis. Evaluation of the Commonwealth Rheumatic Fever Strategy — final report. Canberra: Commonwealth Department of Health, 2017.
- 9. Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review. PLoS Negl Trop Dis 2018; 12: e0006577.
- 10. Yeoh DK, Anderson A, Cleland G, Bowen AC. Are scabies and impetigo “normalised”? A cross‐sectional comparative study of hospitalised children in northern Australia assessing clinical recognition and treatment of skin infections. PLoS Negl Trop Dis 2017; 11: e0005726.
- 11. Wyatt K. Local action funded to eliminate rheumatic heart disease [media release]; Oct 2018. Office of the Hon Ken Wyatt. http://pandora.nla.gov.au/pan/159736/20181031-0031/www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-wyatt140.html (viewed Dec 2018).
- 12. Cannon J, Katzenellenbogen JM, Wyber R, et al. The cost of inaction on rheumatic heart disease: Technical report of the predicted human and economic toll of rheumatic heart disease for Aboriginal and Torres Strait Islander people by 2031. Perth: The END RHD CRE, Telethon Kids Institute, 2018.
- 13. Terreri MT, Ferraz MB, Goldenberg J, et al. Resource utilization and cost of rheumatic fever. J Rheumatol 2001; 28: 1394–1397.
- 14. Kingué S, Ba SA, Balde D, et al. The VALVAFRIC study: a registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis 2016; 109: 321–329.
- 15. Mitchell AG, Belton S, Johnston V, et al. “That heart sickness”: young Aboriginal people's understanding of rheumatic fever. Med Anthropol 2019; 38: 1–14.
- 16. Marika M, Mitchell A, Ralph A, et al. Words from Arnhem land: Aboriginal health messages need to be made with us rather than for us. The Conversation. 2018; 22 Nov. https://theconversation.com/words-from-arnhem-land-aboriginal-health-messages-need-to-be-made-with-us-rather-than-for-us-100655 (viewed July 2019).
- 17. Wyatt K. New Roadmap to Eliminate Rheumatic Heart Disease [media release]; Feb 2018. Office of the Hon Ken Wyatt. http://pandora.nla.gov.au/pan/159736/20181031-0031/www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-wyatt022.html (viewed Feb 2019).
- 18. Australian Labor Party. A fair go for Australia. Labor National Platform: 2018. https://www.alp.org.au/media/1539/2018_alp_national_platform_constitution.pdf (viewed Feb 2019).
No relevant disclosures.